These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8694809)
1. K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells. Nakayama T; Hashimoto Y; Kaneko Y; Kurokawa K Biochem Biophys Res Commun; 1996 Jul; 224(1):180-3. PubMed ID: 8694809 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
3. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Morris TA; DeLorenzo RJ; Tombes RM Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994 [TBL] [Abstract][Full Text] [Related]
4. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577 [TBL] [Abstract][Full Text] [Related]
5. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031 [TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase. Wang QM; Luo X; Kheir A; Coffman FD; Studzinski GP Oncogene; 1998 May; 16(21):2729-37. PubMed ID: 9652739 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein. Yu B; Lane ME; Pestell RG; Albanese C; Wadler S Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757 [TBL] [Abstract][Full Text] [Related]
8. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993 [TBL] [Abstract][Full Text] [Related]
9. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416 [TBL] [Abstract][Full Text] [Related]
10. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745 [TBL] [Abstract][Full Text] [Related]
11. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236 [TBL] [Abstract][Full Text] [Related]
12. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide. Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560 [TBL] [Abstract][Full Text] [Related]
13. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells. Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893 [TBL] [Abstract][Full Text] [Related]
14. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Benaud CM; Dickson RB Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151 [TBL] [Abstract][Full Text] [Related]
15. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S; Lowe M; Herliczek TW; Keyomarsi K Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471 [TBL] [Abstract][Full Text] [Related]
16. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation. Musgrove EA; Sarcevic B; Sutherland RL J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812 [TBL] [Abstract][Full Text] [Related]
17. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512 [TBL] [Abstract][Full Text] [Related]
19. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC; Lin-Shiau SY; Chen CF; Lin JK J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]